Polycystic ovary syndrome is the most common reproductive disorder, affecting one in 10 women of childbearing age.
The "Market Spotlight:
Polycystic Ovary Syndrome (PCOS)" report has been added to ResearchAndMarkets.com's offering.
Epidemiology, diagnosis and management of
Polycystic ovary syndrome. Clin Epidemiol 2014; 6: 1-13.
Polycystic Ovary syndrome is a common gynaecological problem affecting 25 percent of general population.
Abdominal adiposity and the
polycystic ovary syndrome. Trends Endocrinol Metab.
Prevalence of the
polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
Polycystic ovary syndrome (PCOS) is a condition that affects a woman's hormone levels.
Changes in glucose tolerance over time in women with
polycystic ovary syndrome: A controlled study.
Polycystic ovary syndrome is a major cause of infertility due to anovulation.
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders with a prevalence of approximately 60-70% in Chinese obese women of reproductive age.[1] The common manifestations of PCOS are oligomenorrhea, chronic anovulation, hyperandrogenism, hyperinsulinemia, and polycystic ovaries on ovarian ultrasonography.[2] PCOS increases the risks of type 2 diabetes, cardiovascular disease, endometrial cancer, and ovarian cancer.[3],[4] The pathogenesis of PCOS remains unclear, although it is considered to be the result of interaction between genetic, environmental, and lifestyle factors.
KEYWORDS:
Polycystic ovary syndrome, SNP microarray, Whole exome sequencing.
Polycystic ovary syndrome is the most common endocrine disorder in females of reproductive age with a prevalence of up to 20%.
